Immune cells targeting epcam and medical use thereof
AssigneeSuzhou Immunohead Biotechnology Co., Ltd
InventorSuqiong Wang
Life of this patent
Estimating the term…
Abstract
The present invention relates to the technical field of biomedicine, and specifically relates to immune cells targeting EpCAM and a medical use thereof. Provided is a use of immune cells in the preparation of a drug for preventing or treating a tumor; the immune cells are cells for adoptive immune cell therapy, which can target and kill EpCAM-expressing cells; and the tumor expresses EpCAM and is a metastatic tumor.
Claims13
-11. (canceled)
A method for preventing or treating a tumor in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of immune cells wherein the immune cell is a cell for an adoptive immune cell therapy, which can target and kill an EpCAM-expressing cell, and wherein the tumor expresses EpCAm and is a tumor with a metastasis.
A pharmaceutical composition for preventing or treating a tumor, comprising a therapeutically effective amount of immune cells, wherein the immune cell is a cell for an adoptive immune cell therapy, which can target and kill an EpCAM-expressing cell, and wherein the tumor expresses EpCAM and is a tumor with a metastasis.
Dependencies are inferred from the claim text.